CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended		94 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2011
OPERATING
Net loss	$ (2,128,729)	$ (1,097,831)	$ (3,256,094)
Adjustments to reconcile net loss to cash flows used in operating activities:
Depreciation	15,096	8,663	25,169
Patent amortization and impairment			19,629
Amortization of deferred issuance costs	30,392	15,811	46,203
Proceeds advanced (repaid) from stockholder		(17,444)	22,709
Excess value of derivative liability over related loan proceeds		4,493,960	4,493,960
Amortization of note discount	199,433	190,436	389,869
Share based compensation	432,024	641,822	1,073,846
Common shares issued for services	392,760	9,000	401,760
Change in valuation of derivative liability	272,970	(4,959,811)	(4,686,841)
Increase (decrease) in grant proceeds receivable	153,672	168,302	(14,930)
Increase (decrease) in other assets	2,702	(6,349)	(3,647)
Increase in prepaid expenses	(11,985)	(12,697)	(24,682)
Increase in deposits			(3,350)
Increase in accounts payable and accrued expenses	288,812	216,844	505,656
Cash used in operating activities	(352,853)	(685,898)	(1,010,443)
INVESTING
Purchase of property and equipment		(78,310)	(86,989)
Patent costs			(19,629)
Cash used in investing activities		(78,310)	(106,618)
FINANCING
Net proceeds from issuance of convertible notes	470,000	787,425	1,257,425
Cash provided by financing activities	470,000	787,425	1,257,425
Net increase (decrease) in cash and cash equivalents	117,147	23,217	140,364
Cash and cash equivalents, beginning of period	23,217
Cash and cash equivalents, end of period	140,364	23,217	140,364
Cash paid during the year for:
Interest
Income taxes
Common stock issued for services	$ 329,760	$ 9,000	$ 401,760